Certificate of analysis · Apex Laboratory
Lipo-C 10 ml
APX-2026-0517-L
For laboratory research use only. The issue date identifies this certificate; it is not a testing date.
Preview report pages Analytical record
Results & specifications
T01Identity and structure
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Orthogonal identity against specified reference | Conforms to the assigned reference; see identity basisPASS | Conforms to the specified acceptance criterion | M-T01-DEFAULT |
Supporting analytical detail for Orthogonal identity against specified reference
| |||
| Orthogonal fingerprint similarityspectrum/peptide-map comparison; score is not proof of stereochemistry | 0.9994 similarity (0-1)PASS | >= 0.995similarity (0-1) | M-T01-DEFAULT |
Supporting analytical detail for Orthogonal fingerprint similarity
| |||
| L-Methionine component-specific HRMS mass error[M+H]+; exact ion definition independent of whole-blend identity. Reference formula C5H11NO2S. | 0.00997 ppmPASS | -5 to 5ppm | M-T01-BLEND-SELECTIVE-HRMS |
Supporting analytical detail for L-Methionine component-specific HRMS mass error
| |||
| myo-Inositol component-specific HRMS mass error[M+Na]+; exact ion definition independent of whole-blend identity. Reference formula C6H12O6. | 0.05006 ppmPASS | -5 to 5ppm | M-T01-BLEND-SELECTIVE-HRMS |
Supporting analytical detail for myo-Inositol component-specific HRMS mass error
| |||
| Choline chloride component-specific HRMS mass error[C5H14NO]+ (choline cation; chloride excluded); exact ion definition independent of whole-blend identity. Reference formula C5H14ClNO. | 0.09002 ppmPASS | -5 to 5ppm | M-T01-BLEND-SELECTIVE-HRMS |
Supporting analytical detail for Choline chloride component-specific HRMS mass error
| |||
T02Chromatographic purity
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| L-methionine chromatographic puritySingle analyte method scope; intended blend co-components and excipients excluded by analyte-specific selectivity, not denominator manipulation | 99.938 % integrated detector areaPASS | 99.7 to 100% integrated detector area | M-T02-HILIC-CAD |
Supporting analytical detail for L-methionine chromatographic purity
| |||
| myo-inositol chromatographic puritySingle analyte method scope; intended blend co-components and excipients excluded by analyte-specific selectivity, not denominator manipulation | 99.922 % integrated detector areaPASS | 99.7 to 100% integrated detector area | M-T02-HILIC-CAD |
Supporting analytical detail for myo-inositol chromatographic purity
| |||
| Choline chloride chromatographic puritySingle analyte method scope; intended blend co-components and excipients excluded by analyte-specific selectivity, not denominator manipulation | 99.913 % integrated detector areaPASS | 99.7 to 100% integrated detector area | M-T02-HILIC-CAD |
Supporting analytical detail for Choline chloride chromatographic purity
| |||
T05Related substances and degradants
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| L-methionine Unknown U1Same analyte-specific chromatogram as T02; response factor assumed 1.00 for unknowns; area only | 0.031 % integrated detector areaPASS | <= 0.1% integrated detector area | M-T05-DEFAULT |
Supporting analytical detail for L-methionine Unknown U1
| |||
| L-methionine Unknown U2Same analyte-specific chromatogram as T02; response factor assumed 1.00 for unknowns; area only | 0.019 % integrated detector areaPASS | <= 0.1% integrated detector area | M-T05-DEFAULT |
Supporting analytical detail for L-methionine Unknown U2
| |||
| L-methionine Unknown U3Same analyte-specific chromatogram as T02; response factor assumed 1.00 for unknowns; area only | 0.012 % integrated detector areaPASS | <= 0.1% integrated detector area | M-T05-DEFAULT |
Supporting analytical detail for L-methionine Unknown U3
| |||
| L-methionine total related peaksSum of U1+U2+U3; purity plus related areas = 100% | 0.062 % integrated detector areaPASS | <= 0.3% integrated detector area | M-T05-DEFAULT |
Supporting analytical detail for L-methionine total related peaks
| |||
| myo-inositol Unknown U1Same analyte-specific chromatogram as T02; response factor assumed 1.00 for unknowns; area only | 0.039 % integrated detector areaPASS | <= 0.1% integrated detector area | M-T05-DEFAULT |
Supporting analytical detail for myo-inositol Unknown U1
| |||
| myo-inositol Unknown U2Same analyte-specific chromatogram as T02; response factor assumed 1.00 for unknowns; area only | 0.023 % integrated detector areaPASS | <= 0.1% integrated detector area | M-T05-DEFAULT |
Supporting analytical detail for myo-inositol Unknown U2
| |||
| myo-inositol Unknown U3Same analyte-specific chromatogram as T02; response factor assumed 1.00 for unknowns; area only | 0.016 % integrated detector areaPASS | <= 0.1% integrated detector area | M-T05-DEFAULT |
Supporting analytical detail for myo-inositol Unknown U3
| |||
| myo-inositol total related peaksSum of U1+U2+U3; purity plus related areas = 100% | 0.078 % integrated detector areaPASS | <= 0.3% integrated detector area | M-T05-DEFAULT |
Supporting analytical detail for myo-inositol total related peaks
| |||
| Choline chloride Unknown U1Same analyte-specific chromatogram as T02; response factor assumed 1.00 for unknowns; area only | 0.043 % integrated detector areaPASS | <= 0.1% integrated detector area | M-T05-DEFAULT |
Supporting analytical detail for Choline chloride Unknown U1
| |||
| Choline chloride Unknown U2Same analyte-specific chromatogram as T02; response factor assumed 1.00 for unknowns; area only | 0.026 % integrated detector areaPASS | <= 0.1% integrated detector area | M-T05-DEFAULT |
Supporting analytical detail for Choline chloride Unknown U2
| |||
| Choline chloride Unknown U3Same analyte-specific chromatogram as T02; response factor assumed 1.00 for unknowns; area only | 0.018 % integrated detector areaPASS | <= 0.1% integrated detector area | M-T05-DEFAULT |
Supporting analytical detail for Choline chloride Unknown U3
| |||
| Choline chloride total related peaksSum of U1+U2+U3; purity plus related areas = 100% | 0.087 % integrated detector areaPASS | <= 0.3% integrated detector area | M-T05-DEFAULT |
Supporting analytical detail for Choline chloride total related peaks
| |||
T03Active content and assay
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| L-methionine active contentAssigned component material basis; excludes vehicle/excipient/water; salt basis explicitly in identity specification | 250.15 mg/vialPASS | 245 to 255mg/vial | M-T03-DEFAULT |
Supporting analytical detail for L-methionine active content
| |||
| L-methionine label claim assayIndependent calibrated amount / nominal amount x 100; not chromatographic area purity | 100.06 % label claimPASS | 98 to 102% label claim | M-T03-DEFAULT |
Supporting analytical detail for L-methionine label claim assay
| |||
| L-methionine concentrationAmount per nominal 10 mL fill | 25.015 mg/mLPASS | 24.5 to 25.5mg/mL | M-T03-DEFAULT |
Supporting analytical detail for L-methionine concentration
| |||
| myo-inositol active contentAssigned component material basis; excludes vehicle/excipient/water; salt basis explicitly in identity specification | 499.96 mg/vialPASS | 490 to 510mg/vial | M-T03-DEFAULT |
Supporting analytical detail for myo-inositol active content
| |||
| myo-inositol label claim assayIndependent calibrated amount / nominal amount x 100; not chromatographic area purity | 99.992 % label claimPASS | 98 to 102% label claim | M-T03-DEFAULT |
Supporting analytical detail for myo-inositol label claim assay
| |||
| myo-inositol concentrationAmount per nominal 10 mL fill | 49.996 mg/mLPASS | 49 to 51mg/mL | M-T03-DEFAULT |
Supporting analytical detail for myo-inositol concentration
| |||
| Choline chloride active contentAssigned component material basis; excludes vehicle/excipient/water; salt basis explicitly in identity specification | 500.875 mg/vialPASS | 490 to 510mg/vial | M-T03-DEFAULT |
Supporting analytical detail for Choline chloride active content
| |||
| Choline chloride label claim assayIndependent calibrated amount / nominal amount x 100; not chromatographic area purity | 100.175 % label claimPASS | 98 to 102% label claim | M-T03-DEFAULT |
Supporting analytical detail for Choline chloride label claim assay
| |||
| Choline chloride concentrationAmount per nominal 10 mL fill | 50.0875 mg/mLPASS | 49 to 51mg/mL | M-T03-DEFAULT |
Supporting analytical detail for Choline chloride concentration
| |||
T04Blend composition
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| L-methionine component identity | Conforms to specified component identityPASS | Conforms to the specified acceptance criterion | M-T04-DEFAULT |
Supporting analytical detail for L-methionine component identity
| |||
| L-methionine component contentSame independent component assay as T03, not a second independent test | 250.15 mg/vialPASS | 245 to 255mg/vial | M-T04-DEFAULT |
Supporting analytical detail for L-methionine component content
| |||
| myo-inositol component identity | Conforms to specified component identityPASS | Conforms to the specified acceptance criterion | M-T04-DEFAULT |
Supporting analytical detail for myo-inositol component identity
| |||
| myo-inositol component contentSame independent component assay as T03, not a second independent test | 499.96 mg/vialPASS | 490 to 510mg/vial | M-T04-DEFAULT |
Supporting analytical detail for myo-inositol component content
| |||
| Choline chloride component identity | Conforms to specified component identityPASS | Conforms to the specified acceptance criterion | M-T04-DEFAULT |
Supporting analytical detail for Choline chloride component identity
| |||
| Choline chloride component contentSame independent component assay as T03, not a second independent test | 500.875 mg/vialPASS | 490 to 510mg/vial | M-T04-DEFAULT |
Supporting analytical detail for Choline chloride component content
| |||
| L-Methionine isolated component identity definition(S)-2-amino-4-(methylthio)butanoic acid; L-methionine, unoxidized thioether. Reference HILIC retention and chiral amino-acid assay; distinguish methionine sulfoxide/sulfone and D-methionine. | Conforms to the stated component referencePASS | Conforms to the specified acceptance criterion | M-T04-BLEND-SELECTIVE-IDENTITY |
Supporting analytical detail for L-Methionine isolated component identity definition
| |||
| myo-Inositol isolated component identity definitionmyo-Inositol stereoisomer of cyclohexane-1,2,3,4,5,6-hexol; not D-chiro-inositol. Reference HILIC retention and solution NMR stereoisomer fingerprint; sodium adduct alone cannot distinguish inositol isomers. | Conforms to the stated component referencePASS | Conforms to the specified acceptance criterion | M-T04-BLEND-SELECTIVE-IDENTITY |
Supporting analytical detail for myo-Inositol isolated component identity definition
| |||
| Choline chloride isolated component identity definition2-Hydroxy-N, N, N-trimethylethanaminium chloride: one choline cation and one chloride anion. Choline-cation identity plus independent chloride IC assay; neither a protonated intact salt nor chloride-free mass is the weighed salt content. | Conforms to the stated component referencePASS | Conforms to the specified acceptance criterion | M-T04-BLEND-SELECTIVE-IDENTITY |
Supporting analytical detail for Choline chloride isolated component identity definition
| |||
T15Unit uniformity
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| L-methionine individual-unit meanspecified sample/form only | 100.06 % label claimPASS | 98 to 102% label claim | M-T15-DEFAULT |
Supporting analytical detail for L-methionine individual-unit mean
| |||
| L-methionine individual-unit RSDPrecision criterion for the listed specification, independently of AV | 0.3522 %PASS | <= 2% | M-T15-DEFAULT |
Supporting analytical detail for L-methionine individual-unit RSD
| |||
| myo-inositol individual-unit meanspecified sample/form only | 99.992 % label claimPASS | 98 to 102% label claim | M-T15-DEFAULT |
Supporting analytical detail for myo-inositol individual-unit mean
| |||
| myo-inositol individual-unit RSDPrecision criterion for the listed specification, independently of AV | 0.3524 %PASS | <= 2% | M-T15-DEFAULT |
Supporting analytical detail for myo-inositol individual-unit RSD
| |||
| Choline chloride individual-unit meanspecified sample/form only | 100.175 % label claimPASS | 98 to 102% label claim | M-T15-DEFAULT |
Supporting analytical detail for Choline chloride individual-unit mean
| |||
| Choline chloride individual-unit RSDPrecision criterion for the listed specification, independently of AV | 0.3518 %PASS | <= 2% | M-T15-DEFAULT |
Supporting analytical detail for Choline chloride individual-unit RSD
| |||
| Mean extractable volumefill specification; no injection volume recommendation | 10 mL/containerPASS | 9.9 to 10.2mL/container | M-T15-DEFAULT |
Supporting analytical detail for Mean extractable volume
| |||
T06Water content
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Applicability decisionspecified sample/form only | Not applicable — Water is the formulation vehicle; residual-moisture percentage would misdescribe an aqueous formulation. Vehicle quantity is specified separately.N/A — justified | Not applicable — Water is the formulation vehicle; residual-moisture percentage would misdescribe an aqueous formulation. Vehicle quantity is specified separately. | M-T06-DEFAULT |
Supporting analytical detail for Applicability decision
| |||
T07Counterions and associated species
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Chloride identity and stoichiometric consistencyCholine chloride; chloride is intentional, not a toxic elemental impurity | Conforms to specified chloride-containing componentPASS | Conforms to the specified acceptance criterion | M-T07-DEFAULT |
Supporting analytical detail for Chloride identity and stoichiometric consistency
| |||
| Choline chloride: independently assayed chlorideIndependent chloride IC result compared with measured choline chloride content; mass fraction uses Cl35.45 / salt139.62. Chloride is intentional. | 127.174 mg Cl/vialRecorded numeric value: 127.173892PASS | 124.63 to 129.717Lower limit: 124.6304138018756Upper limit: 129.7173694672583mg Cl/vial | M-T07-CHLORIDE-IC |
Supporting analytical detail for Choline chloride: independently assayed chloride
| |||
| Choline:chloride stoichiometric consistencyRatio of independent cation/anion assay means; recovery-controlled measurement. | 1 mol chloride/mol cholinePASS | 0.98 to 1.02mol chloride/mol choline | M-T07-CHLORIDE-IC |
Supporting analytical detail for Choline:chloride stoichiometric consistency
| |||
T08Residual solvents
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| MethanolMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 21.738 ug/mL formulationPASS | <= 3000ug/mL formulation | M-T08-DEFAULT |
Supporting analytical detail for Methanol
| |||
| AcetonitrileMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 8.76 ug/mL formulationPASS | <= 410ug/mL formulation | M-T08-DEFAULT |
Supporting analytical detail for Acetonitrile
| |||
| DichloromethaneMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 3.562 ug/mL formulationPASS | <= 600ug/mL formulation | M-T08-DEFAULT |
Supporting analytical detail for Dichloromethane
| |||
| N, N-dimethylformamideMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 3.811 ug/mL formulationPASS | <= 880ug/mL formulation | M-T08-DEFAULT |
Supporting analytical detail for N, N-dimethylformamide
| |||
| EthanolMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 37.858 ug/mL formulationPASS | <= 5000ug/mL formulation | M-T08-DEFAULT |
Supporting analytical detail for Ethanol
| |||
| AcetoneMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 12.51 ug/mL formulationPASS | <= 5000ug/mL formulation | M-T08-DEFAULT |
Supporting analytical detail for Acetone
| |||
| Ethyl acetateMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 9.308 ug/mL formulationPASS | <= 5000ug/mL formulation | M-T08-DEFAULT |
Supporting analytical detail for Ethyl acetate
| |||
| TolueneMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 1.893 ug/mL formulationPASS | <= 890ug/mL formulation | M-T08-DEFAULT |
Supporting analytical detail for Toluene
| |||
| n-HexaneMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 1.117 ug/mL formulationPASS | <= 290ug/mL formulation | M-T08-DEFAULT |
Supporting analytical detail for n-Hexane
| |||
| BenzeneMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 0.084 ug/mL formulationPASS | <= 2ug/mL formulation | M-T08-DEFAULT |
Supporting analytical detail for Benzene
| |||
T09Elemental impurities
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| LeadTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0129 ug/mL formulationPASS | <= 0.5ug/mL formulation | M-T09-DEFAULT |
Supporting analytical detail for Lead
| |||
| CadmiumTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0079 ug/mL formulationPASS | <= 0.2ug/mL formulation | M-T09-DEFAULT |
Supporting analytical detail for Cadmium
| |||
| ArsenicTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.019 ug/mL formulationPASS | <= 0.5ug/mL formulation | M-T09-DEFAULT |
Supporting analytical detail for Arsenic
| |||
| MercuryTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0065 ug/mL formulationPASS | <= 0.1ug/mL formulation | M-T09-DEFAULT |
Supporting analytical detail for Mercury
| |||
| CobaltTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0207 ug/mL formulationPASS | <= 1ug/mL formulation | M-T09-DEFAULT |
Supporting analytical detail for Cobalt
| |||
| VanadiumTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0222 ug/mL formulationPASS | <= 1ug/mL formulation | M-T09-DEFAULT |
Supporting analytical detail for Vanadium
| |||
| NickelTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0383 ug/mL formulationPASS | <= 2ug/mL formulation | M-T09-DEFAULT |
Supporting analytical detail for Nickel
| |||
| PalladiumTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0101 ug/mL formulationPASS | <= 1ug/mL formulation | M-T09-DEFAULT |
Supporting analytical detail for Palladium
| |||
| PlatinumTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0081 ug/mL formulationPASS | <= 1ug/mL formulation | M-T09-DEFAULT |
Supporting analytical detail for Platinum
| |||
| RhodiumTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0065 ug/mL formulationPASS | <= 1ug/mL formulation | M-T09-DEFAULT |
Supporting analytical detail for Rhodium
| |||
| RutheniumTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0083 ug/mL formulationPASS | <= 1ug/mL formulation | M-T09-DEFAULT |
Supporting analytical detail for Ruthenium
| |||
| IridiumTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0057 ug/mL formulationPASS | <= 1ug/mL formulation | M-T09-DEFAULT |
Supporting analytical detail for Iridium
| |||
T13pH and analytical solution
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| pH of native liquidAs supplied,25.0C; buffer-solution compatibility is not the pH of dry material | 5.51 pHPASS | 4.8 to 6.2pH | M-T13-DEFAULT |
Supporting analytical detail for pH of native liquid
| |||
T14Excipients and preservatives
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Vehicle and preservative compositionExplicit formulation choice, not a statement about actual catalog formulation | Water q.s. declared volume; no added preservativePASS | Conforms to the specified acceptance criterion | M-T14-DEFAULT |
Supporting analytical detail for Vehicle and preservative composition
| |||
T21Appearance and physical inspection
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| AppearanceThree containers under diffuse white illumination | colorless; clear solutionPASS | Conforms to the specified acceptance criterion | M-T21-DEFAULT |
Supporting analytical detail for Appearance
| |||
| Visible foreign matterVisual observation only; subvisible particles reported separately | None observed in 3 inspected unitsPASS | Conforms to the specified acceptance criterion | M-T21-DEFAULT |
Supporting analytical detail for Visible foreign matter
| |||
T10Sterility test
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Sterility: FTMFTM30-35C; tested units only; growth-promotion/suitability controls conform | No growth at 14 days in all 20 unitsPASS | Conforms to the specified acceptance criterion | M-T10-DEFAULT |
Supporting analytical detail for Sterility: FTM
| |||
| Sterility: SCDMSCDM20-25C; tested units only; no sterility assurance level assigned | No growth at 14 days in all 20 unitsPASS | Conforms to the specified acceptance criterion | M-T10-DEFAULT |
Supporting analytical detail for Sterility: SCDM
| |||
T11Bacterial endotoxins
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Bacterial endotoxinsSample reporting limit after1:5 dilution; threshold is and not based on administration route/dose | <0.025 EU/mLPASS | <= 0.1EU/mL | M-T11-DEFAULT |
Supporting analytical detail for Bacterial endotoxins
| |||
T12Microbial enumeration
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| TAMCZero colonies observed from1g or1 mL equivalent filter; report <1, not exact absence | <1 CFU/mLPASS | <= 100CFU/mL | M-T12-DEFAULT |
Supporting analytical detail for TAMC
| |||
| TYMCZero colonies observed from1g or1 mL equivalent filter; report <1, not exact absence | <1 CFU/mLPASS | <= 10CFU/mL | M-T12-DEFAULT |
Supporting analytical detail for TYMC
| |||
| Escherichia coliSpecified-organism enrichment in explicit1g/1 mL scope; not a universal pharmacopeial panel | Not detected in 1 mLPASS | Conforms to the specified acceptance criterion | M-T12-DEFAULT |
Supporting analytical detail for Escherichia coli
| |||
| Staphylococcus aureusSpecified-organism enrichment in explicit1g/1 mL scope; not a universal pharmacopeial panel | Not detected in 1 mLPASS | Conforms to the specified acceptance criterion | M-T12-DEFAULT |
Supporting analytical detail for Staphylococcus aureus
| |||
| Pseudomonas aeruginosaSpecified-organism enrichment in explicit1g/1 mL scope; not a universal pharmacopeial panel | Not detected in 1 mLPASS | Conforms to the specified acceptance criterion | M-T12-DEFAULT |
Supporting analytical detail for Pseudomonas aeruginosa
| |||
| Salmonella speciesSpecified-organism enrichment in explicit1g/1 mL scope; not a universal pharmacopeial panel | Not detected in 1 mLPASS | Conforms to the specified acceptance criterion | M-T12-DEFAULT |
Supporting analytical detail for Salmonella species
| |||
| Candida albicansSpecified-organism enrichment in explicit1g/1 mL scope; not a universal pharmacopeial panel | Not detected in 1 mLPASS | Conforms to the specified acceptance criterion | M-T12-DEFAULT |
Supporting analytical detail for Candida albicans
| |||
T16Biological activity
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Applicability decisionspecified sample/form only | Not applicable — No qualified, reference-traceable potency endpoint is established for this selected identity. Identity/content data cannot justify an invented biological potency value; exploratory biological activity would require a separately defined assay.N/A — justified | Not applicable — No qualified, reference-traceable potency endpoint is established for this selected identity. Identity/content data cannot justify an invented biological potency value; exploratory biological activity would require a separately defined assay. | M-T16-DEFAULT |
Supporting analytical detail for Applicability decision
| |||
T17Protein and conjugate characterization
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Applicability decisionspecified sample/form only | Not applicable — No recombinant protein, polymer conjugate or complex mixture for this material. Defined synthetic peptide identity is characterized under T01; GHK copper speciation, when relevant, is explicit.N/A — justified | Not applicable — No recombinant protein, polymer conjugate or complex mixture for this material. Defined synthetic peptide identity is characterized under T01; GHK copper speciation, when relevant, is explicit. | M-T17-DEFAULT |
Supporting analytical detail for Applicability decision
| |||
T18Process impurities
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Applicability decisionspecified sample/form only | Not applicable — chemical synthesis without cell/tissue manufacturing inputs; HCP, host DNA and Protein A are not relevant. Chemical process impurities are covered under T05/T08/T09.N/A — justified | Not applicable — chemical synthesis without cell/tissue manufacturing inputs; HCP, host DNA and Protein A are not relevant. Chemical process impurities are covered under T05/T08/T09. | M-T18-DEFAULT |
Supporting analytical detail for Applicability decision
| |||
T19Particles and container closure
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Subvisible particles >= 10umAs-supplied liquid or entire dry vial dissolved to stated analytical volume; limits, no injectable compliance claim | 21 particles/containerPASS | <= 6000particles/container | M-T19-DEFAULT |
Supporting analytical detail for Subvisible particles >= 10um
| |||
| Subvisible particles >= 25umAs-supplied liquid or entire dry vial dissolved to stated analytical volume; limits, no injectable compliance claim | 2 particles/containerPASS | <= 600particles/container | M-T19-DEFAULT |
Supporting analytical detail for Subvisible particles >= 25um
| |||
| Vacuum decay package integritymethod vacuum-decay threshold0.20kPa/60s;5um positive defect control. No universal leakage-to-sterility equivalence. | 10/10test closures conform; positive-leak controls detectedPASS | Conforms to the specified acceptance criterion | M-T19-DEFAULT |
Supporting analytical detail for Vacuum decay package integrity
| |||
T20Stability observations
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Reported 6 month assay retentionReported change relative to the initial assay. This report does not assign a retest date or shelf life. | 99.91 % of initial assayPASS | 98 to 102% of initial assay | M-T20-DEFAULT |
Supporting analytical detail for Reported 6 month assay retention
| |||
| Reported 6 month minimum component puritySeparate endpoint; no shelf-life claim | 99.871 % integrated detector areaPASS | 99.7 to 100% integrated detector area | M-T20-DEFAULT |
Supporting analytical detail for Reported 6 month minimum component purity
| |||
| Dating dispositionReported change relative to the initial assay. This report does not assign a retest date or shelf life. | 6 month review point; actual expiry/retest not assignedPASS | Conforms to the specified acceptance criterion | M-T20-DEFAULT |
Supporting analytical detail for Dating disposition
| |||
Method references
How the results are documented
- M-T01-DEFAULT
- Orthogonal chemical/structural identityLC-HRMS/MS plus sequence/connectivity-sensitive reference comparison
- M-T02-HILIC-CAD
- Nonchromophoric component chromatographic response purityHILIC with charged aerosol detection
- M-T05-DEFAULT
- Related substancesStability-indicating LC integration; orthogonal size/charge separation for biologics
- M-T03-DEFAULT
- Calibrated material contentIndependent quantitative LC/CAD, protein assay or bioactivity calibration for IU
- M-T04-DEFAULT
- Component-resolved blend assaySeparate calibrated selective assay for every declared component
- M-T15-DEFAULT
- Individual-unit uniformityTen separate unit preparations and fill measurements
- M-T06-DEFAULT
- WaterCoulometric Karl Fischer
- M-T07-DEFAULT
- Counterion compositionIon chromatography and stoichiometric accounting
- M-T08-DEFAULT
- Residual solvent panelheadspace GC-MS
- M-T09-DEFAULT
- Elemental impurity panelICP-MS
- M-T13-DEFAULT
- pH and solution stateCalibrated potentiometry
- M-T14-DEFAULT
- Excipients/preservativesComponent-specific quantitative LC/CAD or formulation identity
- M-T21-DEFAULT
- AppearanceControlled visual examination
- M-T10-DEFAULT
- Sterility observations in two media with matrix-specific preparationMembrane filtration/rinsing or neutralized direct inoculation for Lemon dispersion
- M-T11-DEFAULT
- Bacterial endotoxinsRecombinant factor C fluorometric assay
- M-T12-DEFAULT
- Microbial enumeration/organismsMembrane filtration enumeration and enrichment
- M-T16-DEFAULT
- Functional biological activityReference-relative concentration-response assay
- M-T17-DEFAULT
- Protein/conjugate characterizationSEC-MALS, CE-SDS, peptide mapping, glycan/PEG profiling
- M-T18-DEFAULT
- Biological process impurity panelHost/process-specific ELISA and qPCR
- M-T01-BLEND-SELECTIVE-HRMS
- Component-specific exact-ion identity for the declared blendComponent-selective LC-HRMS with independently defined molecular ions
- M-T04-BLEND-SELECTIVE-IDENTITY
- Identity definition for each selectively assayed blend componentComponent-selective reference comparison with orthogonal identity controls
- M-T07-CHLORIDE-IC
- Intentional chloride content and choline/chloride molar consistencyIndependent chloride ion chromatography with separate choline-cation assay
- M-T19-DEFAULT
- Particles and package integrityLight obscuration plus vacuum decay
- M-T20-DEFAULT
- Stability observationTime-zero/1/3/6-month trend
Apex Laboratory issues this certificate. Results apply to the stated configuration and lot. Browse all certificates.